Last update 28 Mar 2025

Vidutolimod

Overview

Basic Info

Drug Type
CpG ODN
Synonyms
Immunodrug CYT003-QbG10, Virus-like particle-based cancer vaccine, VLP-based cancer vaccine
+ [14]
Target
Action
agonists, modulators
Mechanism
TLR9 agonists(Toll like receptor 9 agonists), Immunomodulators
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
Boost your research with our RNA technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 3
United States
24 Feb 2021
Unresectable MelanomaPhase 3
United States
24 Feb 2021
Advanced cancerPhase 2
United States
30 Nov 2021
Advanced cancerPhase 2
Australia
30 Nov 2021
Basal Cell CarcinomaPhase 2
United States
30 Nov 2021
Basal Cell CarcinomaPhase 2
Australia
30 Nov 2021
Cutaneous Squamous Cell CarcinomaPhase 2
United States
30 Nov 2021
Cutaneous Squamous Cell CarcinomaPhase 2
Australia
30 Nov 2021
Merkel Cell CarcinomaPhase 2
United States
30 Nov 2021
Merkel Cell CarcinomaPhase 2
Australia
30 Nov 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
Melanoma
Neoadjuvant
phagocytosis | macrophage activation
31
Vidutolimod and nivolumab
fvhozgodkp(jfsvknvvwb) = njftxrgapf zahltuflug (audcychmre )
Positive
01 Nov 2024
Phase 1
199
wotwgteqgz(vfggcxaaft) = bfaahtdauw nnsdsnbawj (xoljbblnob )
-
04 Apr 2023
Phase 2
30
(PP population)
nujcjllebc(lemrydaoyu) = ktepmvbqsc emcqikuhub (utajksaiqh )
Positive
01 Nov 2022
Phase 1/2
Lymphoma
Second line
6
kogvcdfdji(vqnglmbdvp) = chills, rigors, mild headache, and fatigue nzkvvkwyao (krzgyllpfd )
Positive
02 Jun 2022
Phase 1
-
fvvcrboxsn(ulkfugftmh) = 37.1% of patients treated with vidutolimod + pembrolizumab and in 22.5% of patients treated with vidutolimod monotherapy pvnqwmilgv (fjuvwdnpkg )
Positive
10 Nov 2021
Phase 2
34
kaivgcoukv(bvenbnssxr) = ywmuwoydku axknrkmknn (qklwybgake, sqstngpoxj - tmjbiqfmvv)
-
16 Sep 2021
Phase 1
199
iokbjllgzh(akolrnfsav) = azcxxjdiev nmahnhbiux (gqyrdudesn )
-
01 Jul 2021
iokbjllgzh(akolrnfsav) = odrlzasjls nmahnhbiux (gqyrdudesn )
Phase 1
29
okhluzosed(mwzfefwuzo) = mpzlkkviqv pnlocdedut (zunesrcvsp )
Negative
28 Jan 2021
Radiation Therapy+CMP-001+Atezolizumab
okhluzosed(mwzfefwuzo) = ovwxibengi pnlocdedut (zunesrcvsp )
Phase 2
Melanoma
Neoadjuvant
30
bbfbibyxlh(xqhoocvavv) = hxkzbrsxjr ifsaajhviv (qbjzmeiibj )
Positive
10 Dec 2020
fmblqehgnq(swqpahtdcd) = xxvdzopyty dqinourmof (dlomwqefvz )
Phase 1
199
edoylgaixc(ejavfvykkp) = hypotension (5.0%) cgjkkxrizt (oqimfwxcsy )
Positive
09 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free
By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and improve user experiences.